Clinical parameters | PFS | OS | ||||
---|---|---|---|---|---|---|
No.a | HR (95% CI)b | p | No.a | HR (95% CI)b | p | |
Age | Â | Â | 0.762 | Â | Â | 0.414 |
 ≤ 60 years | 43 | 1 |  | 49 | 1 |  |
 > 60 years | 62 | 1.08 (0.67–1.72) |  | 70 | 1.24 (0.74–2.06) |  |
Residual tumor mass |  |  | < 0.001 |  |  | < 0.001 |
 0 mm | 58 | 1 |  | 60 | 1 |  |
 > 0 mm | 47 | 2.41 (1.53–3.90) |  | 57 | 3.80 (2.17–6.65) |  |
Ascites fluid volume | Â | Â | 0.019 | Â | Â | 0.005 |
 ≤ 500 ml | 61 | 1 |  | 66 | 1 |  |
 > 500 ml | 38 | 1.79 (1.10–2.90) |  | 46 | 2.10 (1.25–3.54) |  |
KLK7 mRNAc | Â | Â | 0.025 | Â | Â | 0.055 |
 low | 73 | 1 |  | 82 | 1 |  |
 high | 32 | 1.75 (1.07–2.84) |  | 37 | 1.66 (0.99–2.79) |  |
KLK5 + KLK7 mRNAd |  |  | 0.016 |  |  | 0.080 |
 low | 52 | 1 |  | 60 | 1 |  |
 high | 53 | 1.79 (1.11–2.86) |  | 59 | 1.58 (0.95–2.63) |  |